IMF Virtual Myeloma Community Workshop (MCW): What’s Next? – Managing Myeloma at Relapse (https://www.myeloma.org/videos/imf-virtual-myeloma-community-workshop-mcw-whats-next-managing-myeloma-relapse)
The Virtual Myeloma Community Workshop will focus on topics concerning relapsed/refractory myeloma patients. This second installment in a three-part series focuses on myeloma treatment options at time of relapse. Learn more about treatment response, disease progression and management approaches at time of relapse. We will review treatment strategies, the importance of clinical trials, symptom management, and being a part of treatment decision making to help you live your best life with myeloma. After each presentation with the experts, attendees will have ample time to ask questions.
Welcome and Announcements (https://www.youtube.com/watch?v=T8oIHf9TYng)
Robin Tuohy
Workshop Moderator
IMF Senior Vice President, Patient Support
Myeloma 202: Response, Progression, and What It All Means (https://www.youtube.com/watch?v=T8oIHf9TYng&t=249s)
Joseph Mikhael, MD, Med, FRCPC, FACP, FASCO
IMF Chief Medical Officer
(TGen, City of Hope—Phoenix, AZ)
The Treatment Landscape for Relapsed Myeloma (https://www.youtube.com/watch?v=T8oIHf9TYng&t=1400s)
Brea Lipe, MD
Professor of Medicine
Clinical Director, Myeloma Program at James P. Wilmot Cancer Center
(University of Rochester Medical Center—Rochester, NY)
CAR-T: You’re in the Driver’s Seat (https://www.youtube.com/watch?v=T8oIHf9TYng&t=4234s)
Yi Lin, MD, PhD
Hematologist/Oncologist
Professor of Medicine
(Mayo Clinic—Rochester, MN)
Living Your Best Myeloma Life: Side Effect Management and Patient Empowerment (https://www.youtube.com/watch?v=T8oIHf9TYng&t=6600s)
Rebecca Lu, MSN, FNP-C
IMF Nurse Leadership Board Member
(MD Anderson Cancer Center—Houston, TX)
Faculty Roundtable: Demystifying Clinical Trials (https://www.youtube.com/watch?v=T8oIHf9TYng&t=7801s)
Panel Q&A (https://www.youtube.com/watch?v=T8oIHf9TYng&t=9911s)
Workshop Sponsors:
With Support From: Abbvie, Amgen, GSK, Johnson & Johnson, Karyopharm, Pfizer, Sanofi, and Takeda Oncology
(The IMF is not responsible for content provided by the links below and you may be subject to the Privacy Policy and Terms & Conditions of the destination site(s).)
.png)
